rivastigmine

Generic: rivastigmine

Labeler: zydus pharmaceuticals usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine
Generic Name rivastigmine
Labeler zydus pharmaceuticals usa inc.
Dosage Form PATCH, EXTENDED RELEASE
Routes
TRANSDERMAL
Active Ingredients

rivastigmine 13.3 mg/24h

Manufacturer
Zydus Pharmaceuticals USA Inc.

Identifiers & Regulatory

Product NDC 70710-1198
Product ID 70710-1198_7f578c0e-20d3-4f6d-bb1d-5e99b770ebf0
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206318
Listing Expiration 2026-12-31
Marketing Start 2019-03-06

Pharmacologic Class

Established (EPC)
cholinesterase inhibitor [epc]
Mechanism of Action
cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707101198
Hyphenated Format 70710-1198

Supplemental Identifiers

RxCUI
725021 725023 1308569
UPC
0370710119775 0370710119676 0370710119874
UNII
PKI06M3IW0
NUI
N0000175723 N0000000177

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine (source: ndc)
Generic Name rivastigmine (source: ndc)
Application Number ANDA206318 (source: ndc)
Routes
TRANSDERMAL
source: ndc

Resolved Composition

Strengths
  • 13.3 mg/24h
source: ndc
Packaging
  • 30 POUCH in 1 CARTON (70710-1198-7) / 24 h in 1 POUCH (70710-1198-1)
source: ndc

Packages (1)

Ingredients (1)

rivastigmine (13.3 mg/24h)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TRANSDERMAL"], "spl_id": "7f578c0e-20d3-4f6d-bb1d-5e99b770ebf0", "openfda": {"nui": ["N0000175723", "N0000000177"], "upc": ["0370710119775", "0370710119676", "0370710119874"], "unii": ["PKI06M3IW0"], "rxcui": ["725021", "725023", "1308569"], "spl_set_id": ["64dad603-2389-456b-8c18-d1d40b7e7419"], "pharm_class_epc": ["Cholinesterase Inhibitor [EPC]"], "pharm_class_moa": ["Cholinesterase Inhibitors [MoA]"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (70710-1198-7)  / 24 h in 1 POUCH (70710-1198-1)", "package_ndc": "70710-1198-7", "marketing_start_date": "20190306"}], "brand_name": "Rivastigmine", "product_id": "70710-1198_7f578c0e-20d3-4f6d-bb1d-5e99b770ebf0", "dosage_form": "PATCH, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "70710-1198", "generic_name": "Rivastigmine", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine", "active_ingredients": [{"name": "RIVASTIGMINE", "strength": "13.3 mg/24h"}], "application_number": "ANDA206318", "marketing_category": "ANDA", "marketing_start_date": "20190306", "listing_expiration_date": "20261231"}